RCMI Coordinating Center (RCMI CC) Header Logo

Muller Fabbri, MD, PhD

Title
Faculty RankAssociate Professor
InstitutionUniversity of Hawaii at Manoa
DepartmentCancer Biology
AddressUniversity of Hawaii Cancer Center
701 Ilalo St
Honolulu HI 96813
Phone8085643804
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R01CA215753     (FABBRI, MULLER)Jun 15, 2017 - May 31, 2022
    NIH
    Role of microRNAs released by Tumor Associated Macrophages within Exosomes in the chemoresistance of Neuroblastoma
    Role: Principal Investigator
    R01CA219024     (FABBRI, MULLER)Jan 1, 2018 - Dec 31, 2023
    NIH
    Clinical Significance and Mechanism of Action of Exosomal microRNAs in Neuroblastoma chemoresistance
    Role: Principal Investigator
    R01CA279269     (FABBRI, MULLER)Apr 1, 2024 - Mar 31, 2029
    NIH
    Clinical Implications of Natural Killer-derived exosomal miRNAs in Neuroblastoma
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Fabbri M, Calin GA, Croce CM. Incorrect Immunoblot in Figure Showing TP53 Downstream Effectors in Cell Lines and Primary B-Cell Chronic Lymphocytic Leukemia Samples. JAMA. 2025 Jul 08; 334(2):183-184. PMID: 40489328.
      Citations:    Fields:    
    2. Drula R, Pardini B, Fu X, De Los Santos MC, Jurj A, Pang L, El-Daly SM, Fabris L, Knutsen E, Dragomir MP, Bayraktar R, Li Y, Chen M, Del Vecchio F, Berland L, Dae J, Fan D, Shimizu M, Tran AM, Barzi M, Pioppini C, Gutierrez AM, Ivan C, Meas S, Hall CS, Alahari SK, Berindan-Neagoe I, Fabbri M, Lucci A, Arun B, Anfossi S, Calin GA. 17?-estradiol promotes extracellular vesicle release and selective miRNA loading in ERa-positive breast cancer. Proc Natl Acad Sci U S A. 2023 06 06; 120(23):e2122053120. PMID: 37252969.
      Citations: 18     Fields:    Translation:HumansCells
    3. Untergasser A, Hellemans J, Pfaffl MW, Ruijter JM, van den Hoff MJB, Dragomir MP, Adamoski D, Dias SMG, Reis RM, Ferracin M, Dias-Neto E, Marsh I, Kubista M, Fabbri M, Goel A, Slab? O, Knutsen E, Chen B, Negrini M, Mimori K, Pichler M, Papatriantafyllou M, Anfossi S, Schmittgen TD, Huggett J, Bustin S, Vandesompele J, Calin GA. Disclosing quantitative RT-PCR raw data during manuscript submission: a call for action. Mol Oncol. 2023 05; 17(5):713-717. PMID: 36916500.
      Citations: 3     Fields:    Translation:Humans
    4. Yu Y, Zhao Y, Choi J, Shi Z, Guo L, Elizarraras J, Gu A, Cheng F, Pei Y, Lu D, Fabbri M, Agarwal S, Zhang C, Jung SY, Foster JH, Yang J. ERK Inhibitor Ulixertinib Inhibits High-Risk Neuroblastoma Growth In Vitro and In Vivo. Cancers (Basel). 2022 Nov 10; 14(22). PMID: 36428626.
      Citations:    
    5. Rios de Los Rios J, Enciso J, Vilchis-Ordo?ez A, V?zquez-Ram?rez R, Ramirez-Ramirez D, Balandr?n JC, Rodr?guez-Mart?nez A, Ruiz-Tachiqu?n M, Pompa-Mera E, Mendoza L, Pedraza-Alva G, Mayani H, Fabbri M, Pelayo R. Acute lymphoblastic leukemia-secreted miRNAs induce a proinflammatory microenvironment and promote the activation of hematopoietic progenitors. J Leukoc Biol. 2022 07; 112(1):31-45. PMID: 35674096.
      Citations: 6     Fields:    Translation:Humans
    6. Fanini F, Bandini E, Plousiou M, Carloni S, Wise P, Neviani P, Murtadha M, Foca F, Fabbri F, Vannini I, Fabbri M. MicroRNA-16 Restores Sensitivity to Tyrosine Kinase Inhibitors and Outperforms MEK Inhibitors in KRAS-Mutated Non-Small Cell Lung Cancer. Int J Mol Sci. 2021 Dec 12; 22(24). PMID: 34948154.
      Citations: 7     Fields:    Translation:HumansAnimalsCells
    7. Chin A, Mariscal J, Kim M, Guerra G, Victor B, Qian C, Broseghini E, Posadas E, Freeman MR, Sharma S, Gandellini P, Zaffaroni N, You S, Chan KS, Guarnerio J, Fabbri M, Di Vizio D. miR-1227 Targets SEC23A to Regulate the Shedding of Large Extracellular Vesicles. Cancers (Basel). 2021 Nov 22; 13(22). PMID: 34831007.
      Citations:    
    8. Bartlett B, Gao Z, Schukking M, Menor M, Khadka VS, Fabbri M, Fei P, Deng Y. The miRNA Profile of Inflammatory Colorectal Tumors Identify TGF-? as a Companion Target for Checkpoint Blockade Immunotherapy. Front Cell Dev Biol. 2021; 9:754507. PMID: 34722540.
      Citations:    
    9. Cocks A, Del Vecchio F, Martinez-Rodriguez V, Schukking M, Fabbri M. Pro-tumoral functions of tumor-associated macrophage EV-miRNA. Semin Cancer Biol. 2022 11; 86(Pt 1):58-63. PMID: 34371201.
      Citations: 13     Fields:    Translation:HumansCells
    10. Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov. 2021 08; 20(8):629-651. PMID: 34145432.
      Citations: 777     Fields:    Translation:HumansAnimals
    11. Del Vecchio F, Martinez-Rodriguez V, Schukking M, Cocks A, Broseghini E, Fabbri M. Professional killers: The role of extracellular vesicles in the reciprocal interactions between natural killer, CD8+ cytotoxic T-cells and tumour cells. J Extracell Vesicles. 2021 04; 10(6):e12075. PMID: 33815694.
      Citations: 35     Fields:    Translation:HumansCells
    12. Cocks A, Martinez-Rodriguez V, Del Vecchio F, Schukking M, Broseghini E, Giannakopoulos S, Fabbri M. Diverse roles of EV-RNA in cancer progression. Semin Cancer Biol. 2021 10; 75:127-135. PMID: 33440245.
      Citations: 14     Fields:    Translation:HumansAnimalsCells
    13. Shirinbak S, Chan RY, Shahani S, Muthugounder S, Kennedy R, Hung LT, Fernandez GE, Hadjidaniel MD, Moghimi B, Sheard MA, Epstein AL, Fabbri M, Shimada H, Asgharzadeh S. Combined immune checkpoint blockade increases CD8+CD28+PD-1+ effector T cells and provides a therapeutic strategy for patients with neuroblastoma. Oncoimmunology. 2021 01 04; 10(1):1838140. PMID: 33489468.
      Citations: 24     Fields:    Translation:HumansAnimalsCells
    14. Ludwig S, Sharma P, Wise P, Sposto R, Hollingshead D, Lamb J, Lang S, Fabbri M, Whiteside TL. mRNA and miRNA Profiles of Exosomes from Cultured Tumor Cells Reveal Biomarkers Specific for HPV16-Positive and HPV16-Negative Head and Neck Cancer. Int J Mol Sci. 2020 Nov 13; 21(22). PMID: 33202950.
      Citations: 20     Fields:    Translation:HumansCells
    15. Bandini E, Fanini F, Vannini I, Rossi T, Plousiou M, Tumedei MM, Limarzi F, Maltoni R, Fabbri F, Hrelia S, Cho WCS, Fabbri M. miR-9-5p as a Regulator of the Androgen Receptor Pathway in Breast Cancer Cell Lines. Front Cell Dev Biol. 2020; 8:579160. PMID: 33282861.
      Citations:    
    16. Terracciano D, Buonerba C, Scafuri L, De Berardinis P, Calin GA, Ferrajoli A, Fabbri M, Cimmino A. Perspective: Cancer Patient Management Challenges During the COVID-19 Pandemic. Front Oncol. 2020; 10:1556. PMID: 32984015.
      Citations:    
    17. Fabbri M. Natural Killer Cell-Derived Vesicular miRNAs: A New Anticancer Approach? Cancer Res. 2020 01 01; 80(1):17-22. PMID: 31672842.
      Citations: 21     Fields:    Translation:HumansCells
    18. Fabbri M, Girnita L, Varani G, Calin GA. Decrypting noncoding RNA interactions, structures, and functional networks. Genome Res. 2019 09; 29(9):1377-1388. PMID: 31434680.
      Citations: 75     Fields:    Translation:HumansCells
    19. Vannini I, Fanini F, Fabbri M. Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" Clinical Biochemistry 46 (2013) 918-925. Clin Biochem. 2019 06; 68:58. PMID: 31128843.
      Citations:    Fields:    
    20. Wu CH, Li J, Li L, Sun J, Fabbri M, Wayne AS, Seeger RC, Jong AY. Extracellular vesicles derived from natural killer cells use multiple cytotoxic proteins and killing mechanisms to target cancer cells. J Extracell Vesicles. 2019; 8(1):1588538. PMID: 30891164.
      Citations: 116     Fields:    
    21. Vannini I, Fanini F, Fabbri M. Corrigendum to "MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis" [Clinical Biochemistry 46 (2013) 918-925]. Clin Biochem. 2019 01; 63:162. PMID: 30559003.
      Citations:    Fields:    
    22. Neviani P, Wise PM, Murtadha M, Liu CW, Wu CH, Jong AY, Seeger RC, Fabbri M. Natural Killer-Derived Exosomal miR-186 Inhibits Neuroblastoma Growth and Immune Escape Mechanisms. Cancer Res. 2019 03 15; 79(6):1151-1164. PMID: 30541743.
      Citations: 188     Fields:    Translation:HumansAnimalsCells
    23. Marks DL, Olson RL, Urrutia R, Billadeau DD, Roy N, Calin GA, Fabbri M, Koutsioumpa M, Iliopoulos D, Ordog T, Huebert R, Sarmento O, Bamidele AO, Faubion W, Lomberk GL, Siveke J, Ahuja N, Iovanna J, Hlady RA, Robertson K, Kisiel J, Pin CL, Fernandez-Zapico ME. Epigenetics of gastrointestinal diseases: notes from a workshop. Epigenetics. 2018; 13(4):449-457. PMID: 30056798.
      Citations: 2     Fields:    Translation:HumansCells
    24. Shah MY, Ferracin M, Pileczki V, Chen B, Redis R, Fabris L, Zhang X, Ivan C, Shimizu M, Rodriguez-Aguayo C, Dragomir M, Van Roosbroeck K, Almeida MI, Ciccone M, Nedelcu D, Cortez MA, Manshouri T, Calin S, Muftuoglu M, Banerjee PP, Badiwi MH, Parker-Thornburg J, Multani A, Welsh JW, Estecio MR, Ling H, Tomuleasa C, Dima D, Yang H, Alvarez H, You MJ, Radovich M, Shpall E, Fabbri M, Rezvani K, Girnita L, Berindan-Neagoe I, Maitra A, Verstovsek S, Fodde R, Bueso-Ramos C, Gagea M, Manero GG, Calin GA. Cancer-associated rs6983267 SNP and its accompanying long noncoding RNA CCAT2 induce myeloid malignancies via unique SNP-specific RNA mutations. Genome Res. 2018 04; 28(4):432-447. PMID: 29567676.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    25. Vannini I, Fanini F, Fabbri M. Emerging roles of microRNAs in cancer. Curr Opin Genet Dev. 2018 02; 48:128-133. PMID: 29429825.
      Citations: 83     Fields:    Translation:HumansAnimals
    26. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Publisher Correction: Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2018 01 08; 9(1):160. PMID: 29311577.
      Citations: 3     Fields:    
    27. Fabbri M. MicroRNAs and miRceptors: a new mechanism of action for intercellular communication. Philos Trans R Soc Lond B Biol Sci. 2018 Jan 05; 373(1737). PMID: 29158315.
      Citations: 34     Fields:    Translation:HumansCells
    28. Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF. Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells. Philos Trans R Soc Lond B Biol Sci. 2018 Jan 05; 373(1737). PMID: 29158318.
      Citations: 71     Fields:    Translation:HumansCells
    29. Vannini I, Wise PM, Challagundla KB, Plousiou M, Raffini M, Bandini E, Fanini F, Paliaga G, Crawford M, Ferracin M, Ivan C, Fabris L, Davuluri RV, Guo Z, Cortez MA, Zhang X, Chen L, Zhang S, Fernandez-Cymering C, Han L, Carloni S, Salvi S, Ling H, Murtadha M, Neviani P, Gitlitz BJ, Laird-Offringa IA, Nana-Sinkam P, Negrini M, Liang H, Amadori D, Cimmino A, Calin GA, Fabbri M. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs. Nat Commun. 2017 11 27; 8(1):1801. PMID: 29180617.
      Citations: 29     Fields:    Translation:HumansAnimalsCells
    30. Wen C, Seeger RC, Fabbri M, Wang L, Wayne AS, Jong AY. Biological roles and potential applications of immune cell-derived extracellular vesicles. J Extracell Vesicles. 2017; 6(1):1400370. PMID: 29209467.
      Citations: 112     Fields:    
    31. Samuel P, Fabbri M, Carter DRF. Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles. Proteomics. 2017 Dec; 17(23-24). PMID: 28941129.
      Citations: 33     Fields:    Translation:HumansCells
    32. Guo J, Jayaprakash P, Dan J, Wise P, Jang GB, Liang C, Chen M, Woodley DT, Fabbri M, Li W. PRAS40 Connects Microenvironmental Stress Signaling to Exosome-Mediated Secretion. Mol Cell Biol. 2017 Oct 01; 37(19). PMID: 28674187.
      Citations: 19     Fields:    Translation:HumansAnimalsCells
    33. Nakata R, Shimada H, Fernandez GE, Fanter R, Fabbri M, Malvar J, Zimmermann P, DeClerck YA. Contribution of neuroblastoma-derived exosomes to the production of pro-tumorigenic signals by bone marrow mesenchymal stromal cells. J Extracell Vesicles. 2017; 6(1):1332941. PMID: 28717423.
      Citations: 41     Fields:    
    34. Sempere LF, Keto J, Fabbri M. Exosomal MicroRNAs in Breast Cancer towards Diagnostic and Therapeutic Applications. Cancers (Basel). 2017 Jun 24; 9(7). PMID: 28672799.
      Citations:    
    35. Guire V, Fabbri M, Tsongalis GJ. Not all good things come in big packages. Clin Chem Lab Med. 2017 05 01; 55(5):605-607. PMID: 28343175.
      Citations: 1     Fields:    Translation:Humans
    36. Jong AY, Wu CH, Li J, Sun J, Fabbri M, Wayne AS, Seeger RC. Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells. J Extracell Vesicles. 2017; 6(1):1294368. PMID: 28326171.
      Citations: 145     Fields:    
    37. Ranganathan P, Ngankeu A, Zitzer NC, Leoncini P, Yu X, Casadei L, Challagundla K, Reichenbach DK, Garman S, Ruppert AS, Volinia S, Hofstetter J, Efebera YA, Devine SM, Blazar BR, Fabbri M, Garzon R. Serum miR-29a Is Upregulated in Acute Graft-versus-Host Disease and Activates Dendritic Cells through TLR Binding. J Immunol. 2017 03 15; 198(6):2500-2512. PMID: 28159900.
      Citations: 30     Fields:    Translation:HumansCells
    38. Barbato S, Solaini G, Fabbri M. MicroRNAs in Oncogenesis and Tumor Suppression. Int Rev Cell Mol Biol. 2017; 333:229-268. PMID: 28729026.
      Citations: 33     Fields:    Translation:HumansAnimalsCells
    39. Fanini F, Fabbri M. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art. Semin Cell Dev Biol. 2017 07; 67:23-28. PMID: 27956165.
      Citations: 45     Fields:    Translation:HumansCells
    40. Van Roosbroeck K, Fanini F, Setoyama T, Ivan C, Rodriguez-Aguayo C, Fuentes-Mattei E, Xiao L, Vannini I, Redis RS, D'Abundo L, Zhang X, Nicoloso MS, Rossi S, Gonzalez-Villasana V, Rupaimoole R, Ferracin M, Morabito F, Neri A, Ruvolo PP, Ruvolo VR, Pecot CV, Amadori D, Abruzzo L, Calin S, Wang X, You MJ, Ferrajoli A, Orlowski R, Plunkett W, Lichtenberg TM, Davuluri RV, Berindan-Neagoe I, Negrini M, Wistuba II, Kantarjian HM, Sood AK, Lopez-Berestein G, Keating MJ, Fabbri M, Calin GA. Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers. Clin Cancer Res. 2017 06 01; 23(11):2891-2904. PMID: 27903673.
      Citations: 94     Fields:    Translation:HumansAnimalsCells
    41. Giza DE, Fuentes-Mattei E, Bullock MD, Tudor S, Goblirsch MJ, Fabbri M, Lupu F, Yeung SJ, Vasilescu C, Calin GA. Cellular and viral microRNAs in sepsis: mechanisms of action and clinical applications. Cell Death Differ. 2016 12; 23(12):1906-1918. PMID: 27740627.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    42. Frediani JN, Fabbri M. Essential role of miRNAs in orchestrating the biology of the tumor microenvironment. Mol Cancer. 2016 05 26; 15(1):42. PMID: 27231010.
      Citations: 30     Fields:    Translation:HumansAnimalsCells
    43. Olivieri M, Ferro M, Terreri S, Durso M, Romanelli A, Avitabile C, De Cobelli O, Messere A, Bruzzese D, Vannini I, Marinelli L, Novellino E, Zhang W, Incoronato M, Ilardi G, Staibano S, Marra L, Franco R, Perdon? S, Terracciano D, Czerniak B, Liguori GL, Colonna V, Fabbri M, Febbraio F, Calin GA, Cimmino A. Long non-coding RNA containing ultraconserved genomic region 8 promotes bladder cancer tumorigenesis. Oncotarget. 2016 Apr 12; 7(15):20636-54. PMID: 26943042.
      Citations: 46     Fields:    Translation:HumansCells
    44. Neviani P, Fabbri M. Exosomic microRNAs in the Tumor Microenvironment. Front Med (Lausanne). 2015; 2:47. PMID: 26258125.
      Citations:    
    45. Challagundla KB, Wise PM, Neviani P, Chava H, Murtadha M, Xu T, Kennedy R, Ivan C, Zhang X, Vannini I, Fanini F, Amadori D, Calin GA, Hadjidaniel M, Shimada H, Jong A, Seeger RC, Asgharzadeh S, Goldkorn A, Fabbri M. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst. 2015 Jul; 107(7). PMID: 25972604.
      Citations: 212     Fields:    Translation:HumansCells
    46. Fei F, Joo EJ, Tarighat SS, Schiffer I, Paz H, Fabbri M, Abdel-Azim H, Groffen J, Heisterkamp N. B-cell precursor acute lymphoblastic leukemia and stromal cells communicate through Galectin-3. Oncotarget. 2015 May 10; 6(13):11378-94. PMID: 25869099.
      Citations: 59     Fields:    Translation:HumansAnimalsCells
    47. Ling H, Pickard K, Ivan C, Isella C, Ikuo M, Mitter R, Spizzo R, Bullock M, Braicu C, Pileczki V, Vincent K, Pichler M, Stiegelbauer V, Hoefler G, Almeida MI, Hsiao A, Zhang X, Primrose J, Packham G, Liu K, Bojja K, Gaf? R, Xiao L, Rossi S, Song JH, Vannini I, Fanini F, Kopetz S, Zweidler-McKay P, Wang X, Ionescu C, Irimie A, Fabbri M, Lanza G, Hamilton SR, Berindan-Neagoe I, Medico E, Mirnezami A, Calin GA, Nicoloso MS. The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis. Gut. 2016 06; 65(6):977-989. PMID: 25804630.
      Citations: 91     Fields:    Translation:HumansAnimals
    48. Challagundla KB, Fanini F, Vannini I, Wise P, Murtadha M, Malinconico L, Cimmino A, Fabbri M. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics. Expert Rev Mol Diagn. 2014 Jun; 14(5):565-74. PMID: 24844135.
      Citations: 35     Fields:    Translation:HumansCells
    49. de Rosa F, Fanini F, Guidoboni M, Vannini I, Amadori D, Ridolfi R, Ridolfi L, Fabbri M. MicroRNAs and dendritic cell-based vaccination in melanoma patients. Melanoma Res. 2014 Jun; 24(3):181-9. PMID: 24638153.
      Citations: 6     Fields:    Translation:HumansAnimalsCells
    50. Valeri N, Braconi C, Gasparini P, Murgia C, Lampis A, Paulus-Hock V, Hart JR, Ueno L, Grivennikov SI, Lovat F, Paone A, Cascione L, Sumani KM, Veronese A, Fabbri M, Carasi S, Alder H, Lanza G, Gafa' R, Moyer MP, Ridgway RA, Cordero J, Nuovo GJ, Frankel WL, Rugge M, Fassan M, Groden J, Vogt PK, Karin M, Sansom OJ, Croce CM. MicroRNA-135b promotes cancer progression by acting as a downstream effector of oncogenic pathways in colon cancer. Cancer Cell. 2014 Apr 14; 25(4):469-83. PMID: 24735923.
      Citations: 187     Fields:    Translation:HumansAnimalsCells
    51. Liu SV, Fabbri M, Gitlitz BJ, Laird-Offringa IA. Epigenetic therapy in lung cancer. Front Oncol. 2013; 3:135. PMID: 23755372.
      Citations:    
    52. Galli R, Paone A, Fabbri M, Zanesi N, Calore F, Cascione L, Acunzo M, Stoppacciaro A, Tubaro A, Lovat F, Gasparini P, Fadda P, Alder H, Volinia S, Filippini A, Ziparo E, Riccioli A, Croce CM. Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RAR? and tumor regression. Proc Natl Acad Sci U S A. 2013 Jun 11; 110(24):9812-7. PMID: 23716670.
      Citations: 35     Fields:    Translation:HumansAnimalsCells
    53. Vannini I, Fanini F, Fabbri M. MicroRNAs as lung cancer biomarkers and key players in lung carcinogenesis. Clin Biochem. 2013 Jul; 46(10-11):918-25. PMID: 23396164.
      Citations: 23     Fields:    Translation:HumansAnimals
    54. Fabbri M, Paone A, Calore F, Galli R, Croce CM. A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol. 2013 Feb; 10(2):169-74. PMID: 23296026.
      Citations: 85     Fields:    Translation:HumansAnimalsCells
    55. Fabbri M, Calore F, Paone A, Galli R, Calin GA. Epigenetic regulation of miRNAs in cancer. Adv Exp Med Biol. 2013; 754:137-48. PMID: 22956499.
      Citations: 45     Fields:    Translation:HumansAnimals
    56. Fabbri M. TLRs as miRNA receptors. Cancer Res. 2012 Dec 15; 72(24):6333-7. PMID: 23222301.
      Citations: 59     Fields:    Translation:HumansAnimalsCells
    57. Almeida MI, Nicoloso MS, Zeng L, Ivan C, Spizzo R, Gaf? R, Xiao L, Zhang X, Vannini I, Fanini F, Fabbri M, Lanza G, Reis RM, Zweidler-McKay PA, Calin GA. Strand-specific miR-28-5p and miR-28-3p have distinct effects in colorectal cancer cells. Gastroenterology. 2012 Apr; 142(4):886-896.e9. PMID: 22240480.
      Citations: 112     Fields:    Translation:HumansAnimalsCells
    58. Nishida N, Mimori K, Fabbri M, Yokobori T, Sudo T, Tanaka F, Shibata K, Ishii H, Doki Y, Mori M. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin Cancer Res. 2011 May 01; 17(9):2725-33. PMID: 21220473.
      Citations: 139     Fields:    Translation:HumansCells
    59. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, Desponts C, Teitell M, Baffa R, Aqeilan R, Iorio MV, Taccioli C, Garzon R, Di Leva G, Fabbri M, Catozzi M, Previati M, Ambs S, Palumbo T, Garofalo M, Veronese A, Bottoni A, Gasparini P, Harris CC, Visone R, Pekarsky Y, de la Chapelle A, Bloomston M, Dillhoff M, Rassenti LZ, Kipps TJ, Huebner K, Pichiorri F, Lenze D, Cairo S, Buendia MA, Pineau P, Dejean A, Zanesi N, Rossi S, Calin GA, Liu CG, Palatini J, Negrini M, Vecchione A, Rosenberg A, Croce CM. Reprogramming of miRNA networks in cancer and leukemia. Genome Res. 2010 May; 20(5):589-99. PMID: 20439436.
      Citations: 183     Fields:    Translation:HumansAnimalsCells
    60. Fabbri M. miRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn. 2010 May; 10(4):435-44. PMID: 20465498.
      Citations: 51     Fields:    Translation:Humans
    61. Cohn DE, Fabbri M, Valeri N, Alder H, Ivanov I, Liu CG, Croce CM, Resnick KE. Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol. 2010 Jun; 202(6):656.e1-8. PMID: 20400061.
      Citations: 49     Fields:    Translation:HumansCells
    62. Garzon R, Heaphy CE, Havelange V, Fabbri M, Volinia S, Tsao T, Zanesi N, Kornblau SM, Marcucci G, Calin GA, Andreeff M, Croce CM. MicroRNA 29b functions in acute myeloid leukemia. Blood. 2009 Dec 17; 114(26):5331-41. PMID: 19850741.
      Citations: 235     Fields:    Translation:HumansAnimals
    63. Valeri N, Vannini I, Fanini F, Calore F, Adair B, Fabbri M. Epigenetics, miRNAs, and human cancer: a new chapter in human gene regulation. Mamm Genome. 2009 Sep-Oct; 20(9-10):573-80. PMID: 19697081.
      Citations: 38     Fields:    Translation:HumansAnimals
    64. Calin GA, Cimmino A, Fabbri M, Ferracin M, Wojcik SE, Shimizu M, Taccioli C, Zanesi N, Garzon R, Aqeilan RI, Alder H, Volinia S, Rassenti L, Liu X, Liu CG, Kipps TJ, Negrini M, Croce CM. MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A. 2008 Apr 01; 105(13):5166-71. PMID: 18362358.
      Citations: 375     Fields:    Translation:HumansAnimalsCells
    65. Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F, Fabbri M, Coombes K, Alder H, Nakamura T, Flomenberg N, Marcucci G, Calin GA, Kornblau SM, Kantarjian H, Bloomfield CD, Andreeff M, Croce CM. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood. 2008 Mar 15; 111(6):3183-9. PMID: 18187662.
      Citations: 299     Fields:    Translation:HumansCells
    66. Donati V, Fontanini G, Dell'Omodarme M, Prati MC, Nuti S, Lucchi M, Mussi A, Fabbri M, Basolo F, Croce CM, Aqeilan RI. WWOX expression in different histologic types and subtypes of non-small cell lung cancer. Clin Cancer Res. 2007 Feb 01; 13(3):884-91. PMID: 17289881.
      Citations: 31     Fields:    Translation:Humans
    67. Qin HR, Iliopoulos D, Semba S, Fabbri M, Druck T, Volinia S, Croce CM, Morrison CD, Klein RD, Huebner K. A role for the WWOX gene in prostate cancer. Cancer Res. 2006 Jul 01; 66(13):6477-81. PMID: 16818616.
      Citations: 53     Fields:    Translation:HumansAnimalsCells
    68. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, Magri E, Pedriali M, Fabbri M, Campiglio M, M?nard S, Palazzo JP, Rosenberg A, Musiani P, Volinia S, Nenci I, Calin GA, Querzoli P, Negrini M, Croce CM. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005 Aug 15; 65(16):7065-70. PMID: 16103053.
      Citations: 1822     Fields:    Translation:Humans
    Fabbri's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (213)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

    For technical support please contact support